Skip to main content
Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
248.43
+4.96 (2.04%)
At close: Feb 27, 2026, 4:00 PM EST
248.51
+0.08 (0.03%)
After-hours: Feb 27, 2026, 7:59 PM EST

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $23.99B in the quarter ending September 28, 2025, with 6.77% growth. This brings the company's revenue in the last twelve months to $92.15B, up 5.08% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.

Revenue (ttm)
$92.15B
Revenue Growth
+5.08%
P/S Ratio
6.36
Revenue / Employee
$681,570
Employees
138,200
Market Cap
598.69B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 29, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 2019 Pro Pro Pro
Dec 30, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Jan 1, 2017 Pro Pro Pro
Jan 3, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Eli Lilly and Company 65.18B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Novartis AG 56.67B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

JNJ News

More News